Senseonics (NYSE:SENS) Shares Gap Up – Still a Buy?

Senseonics Holdings, Inc. (NYSE:SENS)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $0.96, but opened at $1.04. Senseonics shares last traded at $0.92, with a volume of 3,827,315 shares trading hands.

Analysts Set New Price Targets

A number of research firms have issued reports on SENS. StockNews.com initiated coverage on shares of Senseonics in a report on Thursday, December 26th. They set a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $2.00 price target on shares of Senseonics in a report on Friday, November 15th.

Senseonics Stock Down 9.6 %

The stock has a 50-day moving average of $0.82 and a 200 day moving average of $0.52. The company has a market capitalization of $495.31 million, a PE ratio of -6.40 and a beta of 0.69. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Insider Buying and Selling at Senseonics

In related news, CEO Timothy T. Goodnow bought 315,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were purchased at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the completion of the purchase, the chief executive officer now directly owns 11,310,355 shares in the company, valued at $3,506,210.05. The trade was a 2.86 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Frederick T. Sullivan purchased 124,933 shares of the firm’s stock in a transaction dated Thursday, December 12th. The shares were bought at an average price of $0.38 per share, with a total value of $47,474.54. Following the purchase, the chief financial officer now owns 2,478,844 shares in the company, valued at $941,960.72. The trade was a 5.31 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company’s stock.

Institutional Trading of Senseonics

Several hedge funds have recently made changes to their positions in SENS. FMR LLC increased its holdings in Senseonics by 48,267.2% in the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after acquiring an additional 167,970 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Senseonics by 3.2% in the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock valued at $2,042,000 after purchasing an additional 179,103 shares during the period. GSA Capital Partners LLP bought a new stake in shares of Senseonics in the third quarter valued at approximately $117,000. Ridgecrest Wealth Partners LLC bought a new position in Senseonics in the 4th quarter worth approximately $60,000. Finally, Symmetry Partners LLC purchased a new position in Senseonics in the 3rd quarter valued at approximately $164,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.